Loading…

Rap1 Signal Controls B Cell Receptor Repertoire and Generation of Self-Reactive B1a Cells

We previously reported that the mice deficient for SPA-1, a Rap1 GTPase-activating protein, developed hematopoietic stem cell disorders. Here, we demonstrate that SPA-1 −/− mice show an age-dependent increase in B220 high B1a cells producing anti-dsDNA antibody and lupus-like nephritis. SPA-1 −/− pe...

Full description

Saved in:
Bibliographic Details
Published in:Immunity (Cambridge, Mass.) Mass.), 2006-04, Vol.24 (4), p.417-427
Main Authors: Ishida, Daisuke, Su, Li, Tamura, Akitoshi, Katayama, Yoshinori, Kawai, Yohei, Wang, Shu-Fang, Taniwaki, Masafumi, Hamazaki, Yoko, Hattori, Masakazu, Minato, Nagahiro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We previously reported that the mice deficient for SPA-1, a Rap1 GTPase-activating protein, developed hematopoietic stem cell disorders. Here, we demonstrate that SPA-1 −/− mice show an age-dependent increase in B220 high B1a cells producing anti-dsDNA antibody and lupus-like nephritis. SPA-1 −/− peritoneal B1 cells revealed the altered Vκ gene repertoire, including skewed Vκ4 usage and the significant Igκ/Igλ isotype inclusion indicative of extensive receptor editing. Rap1GTP induced OcaB gene activation via p38MAPK-dependent Creb phosphorylation, and consistently, SPA-1 −/− immature BM B cells showing high Rap1GTP exhibited the augmented expression of OcaB and Vκ4 genes. SPA-1 −/− BM cells could transfer the autoimmunity in association with the generation of peritoneal B220 high B1a cells in Rag-2 −/− recipients. Finally, a portion of SPA-1 −/− mice developed B1 cell leukemia with hemolytic autoantibody. Present results suggest that the regulated Rap1 signal in the immature B cells plays a role in modifying the B cell receptor repertoire and in maintaining the self-tolerance.
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2006.02.007